https://www.patsnap.com/resources/blog/rd-blog/decontamination-and-sterilization-of-facilities-patent-landscape/ · Patsnap · data cut-off 2026-07-31 · downloaded from the live page
Biosafety & Containment · Patent Landscape
Decontamination and Sterilization of Facilities: Where the Patents Sit
  • 54.9% concentration. The top 5 of 78 ranked assignees hold 296 of 539 records in scope — filing here is dominated by a small set of sterilization equipment makers, not a fragmented field.
  • Filing has cooled from its 2020 peak. After peaking at 50 records in 2020, filings fell from 32 in 2021 to 14 in 2024, a -56% move over that span — though 2025-2026 figures are still filling in under publication lag.
  • A61L dominates, but the tail is thin. 70.7% of records carry an A61L sterilizing/disinfecting class, while packaging, container and analytical classes each sit under 15% — signalling where claim space is still open.
Get a prior-art report on your approach
539
Published Records
55%
Top-5 Share of All Records
-56%
Filing Growth 2021→2024
US
Leading Jurisdiction

Filing growth compares 2021 (32 records) with 2024 (14) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 539 records in scope (CR5), not by the ranked leaders only.

Published byPatsnap Research··7 min readSourced from Patsnap Eureka
Overview

What this landscape covers

This landscape tracks patent activity at the intersection of vaporized hydrogen peroxide, surface decontamination and biological indicator methods, combined with the practical engineering work of cycle development, material compatibility, residual aeration, distribution studies, load configuration and log reduction demonstration. It spans 539 published records filed or published between 2015 and mid-2026, drawn from a search string that pairs core decontamination chemistry and verification tools with the process-engineering terms that separate a lab result from a validated facility-scale cycle.

The scope favours records that document not just a decontamination chemistry or device but its validation — biological indicators, load configuration, aeration and material compatibility all point to claims written for regulatory and commercial deployment rather than bench research alone. That skews the corpus toward equipment makers and away from purely academic disinfectant chemistry.

Filing activity and technology composition, 2015-2026
  1. 1STERIS CORP102
  2. 2REGENERON PHARMACEUTICALS INC61
  3. 3ASP GLOBAL MFG GMBH52
  4. 4ETHICON INC46
  5. 5AMERICAN STERILIZER CO35
  6. 6TOMI ENVIRONMENTAL SOLUTIONS INC30
  7. 7STRYKER CORP29
  8. 8STERIFRE MEDICAL INC20
  9. 9MHM IP LTD18
  10. 10AOBIOME LLC16
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Decontamination and Sterilization of Facilities covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
The Numbers

Filing trend and technology composition

Two views of the same 539-record dataset: how filing activity has moved year over year, and which IPC subclasses the records actually claim into.

Filing activity, 2017-2026

Filings ran from 39 in 2017 to a peak of 50 in 2020, then declined to 14 by 2024, a -56% move over the 2021-2024 span. 2025 and 2026 counts sit lower still, but publication lags filing by roughly 18 months, so those final years are undercounted rather than genuinely quiet.

Filing activity, 2017-2026013253850392017201820195020202021202220232024202522026Most recent year is partial — publication lag means later filings are not yet visible.

Technology composition by IPC subclass

A61L (sterilising and disinfecting) appears in 70.7% of the 539 records, far ahead of A61M devices for body fluids (14.7%) and G01N material analysis and testing (9.1%). Records can carry more than one class, so these shares add up to well over 100% — the read is which branches carry claim density, not a partition of the corpus.

Technology composition by IPC subclassA61L · Sterilising & disinfecting38170.7%A61M · Devices for body fluids7914.7%G01N · Material analysis & testing499.1%A61B · Diagnosis & surgery468.5%B65B · Packaging & wrapping295.4%A61F · Implants & prostheses244.5%A61K · Medicinal preparations234.3%B65D · Containers & packaging213.9%Other24144.7%

Shares are the percentage of the 539 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.

Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Decontamination and Sterilization of Facilities covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.

Go deeper on Decontamination and Sterilization of Facilities with Eureka

This page is one run against one query. Ask Eureka your own question about decontamination and sterilization of facilities and every answer comes back with the patent numbers behind it.

Try Eureka
Key Patents

Most-cited records in the corpus

Representative filing
US20020160440A12002-10-31

Vapor phase decontamination process biological indicator evaluator resistomer (BIER) vessel

AMERICAN STERILIZER COMPANY

A BIER vessel evaluates biological indicators for sterilization processes. By flowing gaseous sterilant, such as vaporized hydrogen peroxide, through a chamber before, during and after introducing the indicators, the indicators are exposed to preselected steady-state conditions, allowing accurate and reproducible evaluation of the indicator response. A door to an opening in the chamber allows introducing the indicators without appreciably disturbing the steady-state conditions inside. After a preselected time, the indicators are removed and evaluated for remaining biological activity.Filed by American Sterilizer Company — this record sits at the methodological core of the corpus: it is the validation apparatus that cycle development and log reduction demonstration claims are tested against.

US20020160440A1 — patent drawing 1US20020160440A1 — patent drawing 2
View full filing
Highest-cited patents in scope
#Publication no.Patent titleCitations
1US6884392B2Apparatus and method for steam reprocessing flexible endoscopes1,074
2US5445792AOptimum hydrogen peroxide vapor sterlization method205
3US6365102B1Method of enhanced sterilization with improved material compatibility172
4US20060008379A1Room decontamination with hydrogen peroxide vapor157
5US20160068793A1Manufacturing within a single-use container147
6US20030063997A1Monitoring sterilant concentration in a sterilization process122
7US20040091389A1Apparataus and method for steam reprocessing flexible endoscopes118
8US20050074359A1Aircraft and passenger decontamination system115
9US5508009AOptimum hydrogen peroxide vapor sterilization system114
10US20150374868A1Sterilization container capable of providing an indication regarding whether or not surgical instruments ster…110

Citation counts inside this corpus skew toward older filings simply because they have had longer to accumulate citations — read them as a signal of influence on the field, not of current filing activity.

Each row carries its publication number; clicking a row searches Eureka by that number.

Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Decontamination and Sterilization of Facilities covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself

Put your own technology through the same analysis


  
Where to run it
Fastest

Eureka on the web

When you want the answer in the next five minutes.

The agent works the prompt against patents and technical literature, citing every source.

Run your analysis now →
For builders

MCP server & REST API

When it has to run inside your own pipeline.

Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.

Browse MCP servers →
Insights

What the data means for filing strategy

Three read-throughs from the concentration, trend and technology figures above.

Concentration
54.9% / top 5
share of 539 records

A small group controls over half the corpus

Five assignees out of 78 ranked hold 296 of the 539 records in scope, with the leader alone at 102. New entrants are not filing into empty ground — they are filing adjacent to, or directly over, a small set of incumbents whose claim estates already cover the core vaporized hydrogen peroxide and biological indicator methods.

Top 10 combined reach 75.9% of all records.
Momentum
-56%
2021 to 2024 filings

Activity has cooled from its 2020 peak

Filings peaked at 50 records in 2020 and dropped from 32 in 2021 to 14 in 2024. That is a genuine three-year contraction, not a data artefact — though the 2025-2026 counts should be read with the 18-month publication lag in mind rather than treated as further decline.

Peak year: 2020 at 50 records.
Composition
70.7%
of records carry A61L

Core sterilizing claims dominate, adjacent classes are thin

A61L appears in over two-thirds of records, while packaging (B65B, 5.4%), containers (B65D, 3.9%) and implant-adjacent classes (A61F, 4.5%) each sit under 15%. That gap is where load configuration and packaging-integrated decontamination claims remain comparatively unclaimed.

A61M devices for body fluids is the next-largest class at 14.7%.
Eureka AI Agent
Looking for what nobody has claimed yet?

Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to decontamination and sterilization of facilities, with the prior art for and against each one.

Find the white space →
Co-filing pattern
AssigneeCo-assigneeShared families
Steris CorporationCENTANNI MICHAEL A6
Steris CorporationBACIK MICHAEL A4
Steris CorporationWIGET PAUL W3
Steris CorporationWEISS RICHARD A3
Steris CorporationMEILANDER TIMOTHY W3
Steris CorporationMCVEY IAIN F3
Steris CorporationPASMORE MARK E2
Steris CorporationKOZAK JANUSZ K2

Co-assignee activity is limited to 10 identified pairs, concentrated around one leading assignee and a small set of named inventors — a sign that most filings in this space are prosecuted in-house rather than through joint ventures.

Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Decontamination and Sterilization of Facilities covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Players

Who is filing, and where the gate sits

The ranking covers 78 assignees across the full 539-record corpus. Filing here is led by sterilization equipment manufacturers, with pharmaceutical and medical device makers filing into adjacent validation and packaging claims.

Leader
102 records
single top assignee

One assignee anchors the field

The leading assignee's 102 records is nearly double the fifth-place total of 35, reflecting decades of continuous filing into core vaporized hydrogen peroxide cycle and BIER vessel methods.

Fifth place sits at 35 records; tenth at 16.
Recent momentum
0-1 filings
latest year, leading assignees

Momentum has flattened across the top of the ranking

Recent-year filing counts for the largest assignees sit at zero or one, including a -100% YoY move for one major pharmaceutical filer. That is consistent with the broader post-2020 filing decline rather than any single company retreating from the space.

Publication lag means the most recent year understates true filing activity.
Co-filing
10 pairs
identified co-assignee pairs

Collaboration is narrow and inventor-anchored

The strongest co-assignee pairs link one incumbent sterilization company to a small set of named inventors rather than to other corporate assignees, suggesting prosecution stays largely internal even at the top of the ranking.

Strongest pair recorded at 6 co-filed records.
🔍
Under-claimed branches worth checking before filing
Sub-areas where record counts and class density are comparatively thin relative to the core sterilizing claims.
packaging-integrated decontaminationload configuration validationresidual aeration monitoringdistribution study instrumentationmaterial compatibility testing protocols
Rank all filers by momentum →
Recent-year filing momentum by assignee
AssigneeRecent yearYoY
Steris Corporation1—
Steris Corporation0—
ASP (Advanced Sterilization Products) Global0—
Regeneron Pharmaceuticals Inc.0-100%
ASP Global Manufacturing GmbH0—
Tomi Environmental Solutions Inc.0—
Stryker Corporation0—
Sterifre Medical Inc.0—
Source: Patsnap Eureka. Assignee-level momentum. Derived from a Patsnap search on Decontamination and Sterilization of Facilities covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's Next

Where to take this next

The figures above describe the shape of the field. Turning that into a filing or freedom-to-operate decision means going deeper on specific claims and specific assignees.

Map the top assignees' active claim families

The top 5 hold 54.9% of all 539 records — before filing near their core methods, check which specific claims in their families are still in force and in which jurisdictions.

Explore assignee portfolios in Eureka

Stress-test a white-space claim

Packaging-integrated decontamination and load configuration validation show thinner class density than core A61L sterilizing claims — a targeted prior-art pull will confirm whether that gap is real or just under-indexed.

Run a white-space search in Eureka

Track the post-2020 filing pattern

The move from 32 filings in 2021 to 14 in 2024 is a real contraction, but 2025-2026 data is still incomplete. Set up ongoing monitoring rather than relying on a single snapshot.

Set up filing alerts in Eureka
Source: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Decontamination and Sterilization of Facilities covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ

Common questions on this landscape

Answers are grounded in the same dataset. Derived from a Patsnap search on Decontamination and Sterilization of Facilities covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP

Research Decontamination and Sterilization of Facilities in depth with Eureka

Go past this page: query the whole decontamination and sterilization of facilities corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.

Try Eureka

Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.

Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.

Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.

Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.

Help us improve

Something wrong, out of date, or missing on this page? Tell us and it goes straight to the team that maintains it.